Interleukin 21, interleukin 23, and transforming growth factor β1 in HLA-A29-associated birdshot retinochoroidopathy

American Journal of Ophthalmology

Volumn 156, Issue 2, 2013, Pages

  Yang, Paul ^a,b   Foster, C Stephen ^a,b,c  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

^b Massachusetts Eye Research and Surgery Institute   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A29 ANTIGEN; HLA ANTIGEN CLASS 1; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 28; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIRDSHOT RETINOCHORIODOPATHY; BIRDSHOT RETINOCHOROIDOPATHY; BLOOD SAMPLING; CHORIORETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOMODULATION; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE; TH17 CELL;

EID: 84880572235     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.03.004     Document Type: Article

References (40)

1. K.H. Shah, R.D. Levinson, and F. Yu Birdshot chorioretinopathy Surv Ophthalmol 50 6 2005 519 541
2. D. Monnet, and A.P. Brezin Birdshot chorioretinopathy Curr Opin Ophthalmol 17 2006 545 550
3. R.B. Nussenblatt, K.K. Mittal, S. Ryan, W.R. Green, and A.E. Maumenee Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen Am J Ophthalmol 94 2 1982 147 158
4. C. Pagnoux, A. Mahr, and A. Aouba Extraocular manifestations of birdshot chorioretinopathy in 118 French patients Presse Med 39 5 2010 e97 102
5. A.T. Vitale, A. Rodriquez, and C.S. Foster Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy Ophthalmology 101 5 1994 822 831
6. S. Kiss, M. Ahmed, E. Letko, and C.S. Foster Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy Ophthalmology 112 6 2005 1066 1071
7. M.D. Becker, M.S. Wertheim, J.R. Smith, and J.T. Rosenbaum Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression Ocul Immunol Inflamm 13 4 2005 289 293
8. H.M. Holak, S. Szymaniec, and S. Holak The pathogenesis of Birdshot chorioretinopathy Surv Ophthalmol 51 4 2006 446 447
9. Y. Szpak, J.C. Vieville, and T. Tabary Spontaneous retinopathy in HLA-A29 transgenic mice Proc Natl Acad Sci U S A 98 5 2001 2572 2576
10. Y. de Kozak, S. Camelo, and M. Pla Pathological aspects of spontaneous uveitis and retinopathy in HLA-A29 transgenic mice and in animal models of retinal autoimmunity: relevance to human pathologies Ophthalmic Res 40 3-4 2008 175 180
11. F. Boisgerault, I. Khalil, and V. Tieng Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy Proc Natl Acad Sci U S A 93 8 1996 3466 3470
12. R.B. Nussenblatt, M.M. Rodrigues, W.B. Wacker, S.J. Cevario, M.C. Salinas-Carmona, I. Gery, and A. Cyclosporin Inhibition of experimental autoimmune uveitis in Lewis rats J Clin Invest 67 4 1981 1228 1231
13. P.A. Gaudio, D.B. Kaye, and J.B. Crawford Histopathology of birdshot retinochoroidopathy Br J Ophthalmol 86 12 2002 1439 1441
14. R.D. Levinson, Z. Du, and L. Luo Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals Genes Immun 9 3 2008 249 258
15. J.J. Kuiper, T. Mutis, W. de Jager, J.D. de Groot-Mijnes, and A. Rothova Intraocular interleukin-17 and proinflammatory cytokines in HLA-A29-associated birdshot chorioretinopathy Am J Ophthalmol 152 2 2011 177 182.e1
16. R.D. Levinson, A. Brezin, A. Rothova, M. Accorinti, and G.N. Holland Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference Am J Ophthalmol 141 1 2006 185 187
17. K. Nagata, K. Maruyama, and K. Uno Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis Invest Ophthalmol Vis Sci 53 7 2012 3827 3833
18. A. Amadi-Obi, C.R. Yu, and X. Liu TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 Nat Med 13 6 2007 711 718
19. M. Chabaud, F. Fossiez, J.L. Taupin, and P. Miossec Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines J Immunol 161 1 1998 409 414
20. G.G. Krueger, R.G. Langley, and C. Leonardi A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis N Engl J Med 356 6 2007 580 592
21. M.C. Fantini, G. Monteleone, and T.T. MacDonald IL-21 comes of age as a regulator of effector T cells in the gut Nature 1 2 2008 110 115
22. A. Vaknin-Dembinsky, K. Balashov, and H.L. Weiner IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production J lmmunol 178 2006 7766 7774
23. S. Jiang, X. Liu, and L. Luo Elevated serum IL-23 correlates with intraocular inflammation after cataract surgery in patients with Vogt-Koyanagi-Harada disease Br J Ophthalmol 94 8 2010 1078 1082
24. F. Li, P. Yang, X. Liu, C. Wang, S. Hou, and A. Kijlstra Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease Arch Ophthalmol 128 11 2010 1449 1454
25. W. Chi, X. Zhu, and P. Yang Upregulated IL-23 and IL-17 in Behçet patients with active uveitis Invest Ophthalmol Vis Sci 49 7 2008 3058 3064
26. G. Geri, B. Terrier, and M. Rosenzwajg Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease J Allergy Clin Immunol 128 3 2011 655 664
27. L. Zhou, I.I. Ivanov, and R. Spolski IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways Nat Immunol 8 9 2007 967 974
28. P. Miossec, T. Korn, and V.K. Kuchroo Interleukin-17 and type 17 helper T cells N Engl J Med 361 9 2009 888 898
29. T. Korn, E. Bettelli, and W. Gao IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells Nature 448 2007 484 487
30. R. Nurieva, X.O. Yang, and G. Martinez Essential autocrine regulation by IL-21 in the generation of inflammatory T cells Nature 448 2007 480 483
31. E. Bettelli, Y. Carrier, and W. Gao Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 7090 2006 235 238
32. N. Manel, D. Unutmaz, and D.R. Littman The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat Nat Immunol 9 6 2008 641 649
33. I. Kryczek, A.T. Bruce, and J.E. Gudjonsson Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis J Immunol 181 7 2008 4733 4741
34. E.B. Suhler, J.R. Smith, and M.S. Wertheim A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes Arch Ophthalmol 123 7 2005 903 912
35. L. Sobrin, J.J. Huang, W. Christen, C. Kafkala, P. Choopong, and C.S. Foster Daclizumab for treatment of birdshot chorioretinopathy Arch Ophthalmol 126 2 2008 186 191
36. W. Hueber, D.D. Patel, and T. Dryja Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis Sci Transl Med 2 52 2010 52 72
37. J.M. Benson, D. Peritt, and B.J. Scallon Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders MAbs 3 6 2011 535 545
38. K.E. Lewis, S. Bort, and J. Bilsborough Anti-IL-21 monoclonal antibody reduces disease severity and inflammatory cytokines in a murine model of psoriasis and colitis J Immunol 182 2009 97.16
39. R. Spolski, and W.J. Leonard Interleukin-21: basic biology and implications for cancer and autoimmunity Annu Rev Immunol 26 2008 57 79
40. G.J. Prud'homme Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations Lab Invest 87 11 2007 1077 1091